Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 42 of 42 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company AegisCN LLC | Activity: Research and Development | Company Description AegisCN develops technologies and treatments targeting neurological diseases and inflammation. | Location Durham |
| |
Company Aestas Pharma Inc. | Activity: Research and Development | Company Description Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the detection, early treatment and reversal of Alzheimer’s disease when clinical signs are not yet pronounced. | Location Durham |
| |
Company Altavera Analytics | Activity: Contract Research and Testing | Company Description Altavera Analytics provides custom solutions for bioinformatics, utilizing cloud-based workflows and statistical analysis of genomic data. Altavera specializes in biomedicine, including immunology and neurology, as well as agricultural applications, including plant molecular biology and CRISPR screens. | Location Durham |
| |
Company Arrivo BioVentures LLC | Activity: Research and Development | Company Description Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions. | Location Morrisville |
| |
Company Avicenna Biosciences Inc. | Activity: Research and Development | Company Description Avicenna Biosciences is a drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate optimization process for small molecule drug development. | Location Durham |
| |
Company Black Swan Pharmaceuticals Inc. | Activity: Research and Development | Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. | Location Wake Forest |
| |
Company Centaur Bio Inc. | Activity: Research and Development | Company Description Centaur Bio develops technology that facilitates precision drug delivery, which will potentially improve treatments for solid tumors and CNS disorders. | Location Charlotte |
| |
Company CLAIRIgene LLC | Activity: Research and Development | Company Description CLAIRIgene develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. | Location Durham |
| |
Company Cloud Pharmaceuticals Inc. | Activity: Contract Research and Testing | Company Description Cloud Pharmaceuticals designs and develops novel drug molecules using computational design for a wide range of therapeutic areas including cancer, inflammation, CNS disorders and rare diseases. | Location Research Triangle Park |
| |
Company CogniKey Pharma LLC | Activity: Contract Research and Testing | Company Description CogniKey Pharma develops drugs to treat cognitive impairment in CNS disorders. CogniKey has a special interest in the treatment of Mild Cognitive Impairment (MCI). | Location Winston-Salem |
| |
Company Cognosci Inc. | Activity: Research and Development | Company Description Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications. | Location Durham |
| |
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill |
| |
Company ENVIGEN Pharmaceuticals Inc. | Activity: Research and Development | Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. | Location Durham |
| |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill |
| |
Company Ironshore Pharmaceuticals Inc. | Activity: Sales and Operations | Company Description Ironshore Pharmaceuticals develops, commercializes and distributes novel pharmaceuticals, including a novel oral treatment for ADHD with delayed-release properties. | Location Morrisville |
| |
Company Karamedica Inc. | Activity: Research and Development | Company Description Karamedica has developed a plasma treatment of batch quantities of chitosan and other biopolymers in order to lower endotoxin levels. Karamedica is also currently developing a nanoparticle therapy for cerebral amyloid angiopathy. | Location Raleigh |
| |
Company Krenitsky Pharmaceuticals Inc. | Activity: Research and Development | Company Description Krenitsky Pharmaceuticals discovers and develops drug candidates, with a focus on disorders of the nervous system. | Location Chapel Hill |
| |
Company LadeRx LLC | Activity: Research and Development | Company Description LadeRx is developing new technology for diagnostic radiology. | Location Durham |
| |
Company LVM Biosciences Inc. | Activity: Research and Development | Company Description LVM Biosciences develops therapeutics for epilepsy, stroke, anxiety, migraine, and pain. | Location Chapel Hill |
| |
Company Mind Medicine Inc. | Activity: Research and Development | Company Description Mind Medicine is a clinical-stage biopharmaceutical company developing products using the therapeutic potential of psychedelics to treat brain health disorders, with a focus on psychiatry, addiction, pain and neurology. | Location Durham |
| |
Company NeuroGT Inc. | Activity: Research and Development | Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. | Location Chapel Hill |
| |
Company North Carolina Clinical Research | Activity: Contract Research and Testing | Company Description North Carolina Clinical Research conducts phase 1 through 4 trials at its outpatient clinical research facility. Study indications include allergy (seasonal and perennial), asthma, COPD, vaccine, migraine, bioequivalent studies and celiac disease. | Location Raleigh |
| |
Company Olfax LLC | Activity: Research and Development | Company Description Olfax Medical is developing nasally administered therapeutics to help patients avoid the harmful and addictive side effects of systemic pharmaceuticals. | Location Asheville |
| |
Company Osmotica Pharmaceutical Corp. | Activity: Research and Development | Company Description Osmotica Pharmaceutical specializes in drug-delivery technologies and neurology-based therapies, including a treatment for Parkinson's disease. | Location Wilmington |
| |
Company PETNET Solutions Inc. (Winston-Salem) | Activity: Production and Manufacturing | Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. | Location Winston-Salem |
| |
Company PETNET Solutions Inc., A Siemens Healthineers Company (Durham) | Activity: Production and Manufacturing | Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. | Location Durham |
| |
Company Pinnacle Hill LLC | Activity: Research and Development | Company Description Pinnacle Hill, a joint venture of UNC-Chapel Hill and Deerfield Management, works with faculty to accelerate the development of their research projects to discover and develop new drugs and therapies for unmet needs. | Location Chapel Hill |
| |
Company Praetego Inc. | Activity: Research and Development | Company Description Praetego is preclinical stage pharmaceutical company committed to improving health outcomes by addressing chronic diseases of aging, starting with Alzheimer’s Disease. Praetego’s novel small molecules inhibit a systemic driver of oxidative stress at the initiation of pathology. | Location Research Triangle Park |
| |
Company Regennova Inc. | Activity: Research and Development | Company Description Regennova develops therapeutics for inflammatory diseases and neurological disorders, including cerebral stroke, traumatic brain injury, Alzheimer's and sepsis. | Location Durham |
| |
Company Revivo Therapeutics Inc. | Activity: Research and Development | Company Description Revivo Therapeutics is a clinical stage company developing therapies for cognitive dysfunction and neuroprotection. | Location Durham |
| |
Company Sentiens LLC | Activity: Research and Development | Company Description Sentiens develops nutraceutical products targeting addictive behavior. | Location Charlotte |
| |
Company SiNON Nano Sciences Inc. | Activity: Research and Development | Company Description SiNON is developing technology to treat neurological diseases by increasing the ability of drugs to cross the blood brain barrier (BBB). | Location Durham |
| |
Company SpringWorks Therapeutics LLC | Activity: Research and Development | Company Description SpringWorks Therapeutics develops standalone and combination therapies with a focus on rare diseases and oncology, including plexiform neurofibroma, desmoid tumors, RAS/RAF mutant solid tumors and CNS disorders. Its initial portfolio is from Pfizer. | Location Durham |
| |
Company Synthon Pharmaceuticals Inc. | Activity: Sales and Operations | Company Description Synthon Pharmaceuticals develops and manufactures generics, as well as specialty pharmaceuticals and biosimilars in key therapeutic areas of oncology and multiple sclerosis. The Durham location is a regulatory office. | Location Research Triangle Park |
| |
Company T3D Therapeutics Inc. | Activity: Research and Development | Company Description T3D Therapeutics is developing a disease-modifying drug therapy for Alzheimer’s disease that may improve multiple disease defects. T3D is also targeting treatments for other neurodegenerative diseases including Huntington's Disease. | Location Research Triangle Park |
| |
Company Taysha Gene Therapies Inc. | Activity: Production and Manufacturing | Company Description Taysha Gene Therapies develops and manufactures gene therapies for the treatment of monogenic diseases of the central nervous system (CNS), both in rare and large patient populations. | Location Research Triangle Park |
| |
Company Tellus Therapeutics Inc. | Activity: Research and Development | Company Description Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. | Location Research Triangle Park |
| |
Company Tenax Therapeutics Inc. | Activity: Research and Development | Company Description Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market. | Location Morrisville |
| |
Company TregTherapeutics Inc. | Activity: Research and Development | Company Description TregTherapeutics develops tolerogenic therapies to treat autoimmune disease. The approach uses endogenous antigens to personalize therapy for any patient and/or disease. | Location Chapel Hill |
| |
Company vTv Therapeutics LLC | Activity: Research and Development | Company Description vTv Therapeutics is a clinical-stage biopharmaceutical company developing orally administered small molecule drug candidates to fill significant unmet medical needs in Alzheimer's disease (AD), diabetes and inflammatory disorders. | Location High Point |
| |
Company Zarbio LLC | Activity: Research and Development | Company Description Zarbio develops pathophysiology-based treatments for neurodegenerative diseases such as Alzheimer's disease. | Location Chapel Hill |
| |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill |